Landai Technology Group Corp., (002765.SZ) announced a forecasted net profit of 130 million to 155 million RMB for the fiscal year of 2024, turning around from a loss.
Landa Technology (002765.SZ) released its performance forecast for 2024, expecting a full-year attributable to the shareholders of the listed company...
Landai Technology Group Corp. (002765.SZ) released its performance forecast for the year 2024, expecting a net profit attributable to shareholders of the listed company of 130 million to 155 million yuan, turning losses into gains year-on-year.
Reasons for the performance change: In the power transmission business, the company focuses on new energy vehicle core components, improves production capacity and product quality, deepens relationships with high-quality customers, increases the contribution of core products, grows operating income, continues to reduce costs and increase efficiency, raises the gross profit margin of some products, and sees a corresponding increase in profit; in the touch display sector, the industry shows signs of recovery, the company seizes the development opportunities of cover glass and car touch screens, actively expands major customer base, achieves a significant growth in operating income, and sees profits rise compared to the previous year.
Related Articles

US Stock Market Move | Partial encryption mining concept stocks fluctuate and rise, TeraWulf (WULF.US) rises nearly 5%.

US Stock Market Move | Fujian Eastern Red (ORIS.US) Soars Over 25% and Plans to Acquire Controlling Stake in Hubei Daguan Tea Industry Group.

US Stock Market Move | New antiemetic drug Nereus approved by FDA, Vanda Pharmaceuticals Inc. (VNDA.US) surges over 32%
US Stock Market Move | Partial encryption mining concept stocks fluctuate and rise, TeraWulf (WULF.US) rises nearly 5%.

US Stock Market Move | Fujian Eastern Red (ORIS.US) Soars Over 25% and Plans to Acquire Controlling Stake in Hubei Daguan Tea Industry Group.

US Stock Market Move | New antiemetic drug Nereus approved by FDA, Vanda Pharmaceuticals Inc. (VNDA.US) surges over 32%






